National Bank of Canada’s Health Catalyst HCAT Stock Holding History

National Bank of Canada’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-297	Closed	-$1.12K	–	3005
2025 Q2	$1.12K	Buy	+297	New	+$1.17K	﹤0.01%	2686
2023 Q4	–	Sell	-79,749	Closed	-$779K	–	2789
2023 Q3	$779K	Hold	79,749	–	–	﹤0.01%	1265
2023 Q2	$975K	Hold	79,749	–	–	﹤0.01%	1153
2023 Q1	$947K	Buy	79,749 +22,841	+40%	+$291K	﹤0.01%	1074
2022 Q4	$605K	Hold	56,908	–	–	﹤0.01%	1224
2022 Q3	$584K	Hold	56,908	–	–	﹤0.01%	1128
2022 Q2	$876K	Buy	56,908 +8,233	+17%	+$140K	﹤0.01%	1058
2022 Q1	$1.09M	Buy	+48,675	New	+$1.38M	﹤0.01%	1068

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

National Bank of Canada's HCAT Position: Q3 2025 in Review

National Bank of Canada sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 297 shares — an estimated $1.12K sold.

National Bank of Canada first reported a position in HCAT in Q1 2022 and held it in 8 quarters. The position peaked at $1.09M in Q1 2022. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

National Bank of Canada reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
National Bank of Canada sold 297 Health Catalyst shares in Q3 2025, an estimated $1.12K.
National Bank of Canada first reported a position in Health Catalyst in Q1 2022 and held it in 8 quarters.
National Bank of Canada's Health Catalyst position peaked at $1.09M in Q1 2022.
145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.